General Spectrum of Activity
Targeted or empiric therapy for gram positive infections including skin and soft tissue, and pneumonia when first line therapies are precluded by allergy, organism resistance or intolerance/adverse drug reaction.
Covers MRSA and VRE.
CBC at least once/week
Visual testing for therapy >3 months or if symptoms develop on therapy.
IV Administration: 600 mg premixed bags; infuse over 60 min (Premixed bags are not compatible with pumps used by Community IV Program)
NLPDP Status (PO): Special Authorization required
Special Authorization Required
Antimicrobial class: Oxazolidinone
Pregnancy category: C
Average serum half life: 5 hours
CSF penetration: Therapeutic
Lung penetration: Therapeutic
Urine penetration: Therapeutic